Derek Dubay to Kaplan-Meier Estimate
This is a "connection" page, showing publications Derek Dubay has written about Kaplan-Meier Estimate.
Connection Strength
0.827
-
A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy. J Vasc Interv Radiol. 2017 Feb; 28(2):231-237.e2.
Score: 0.126
-
Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma. Am Surg. 2016 Nov 01; 82(11):1133-1139.
Score: 0.125
-
The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs. Am J Transplant. 2015 Feb; 15(2):541-6.
Score: 0.111
-
Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma. HPB (Oxford). 2014 Dec; 16(12):1095-101.
Score: 0.107
-
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function. HPB (Oxford). 2014 Jul; 16(7):648-55.
Score: 0.106
-
Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. HPB (Oxford). 2014 Apr; 16(4):327-35.
Score: 0.100
-
Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford). 2012 Sep; 14(9):625-34.
Score: 0.092
-
Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma. HPB (Oxford). 2016 10; 18(10):843-850.
Score: 0.031
-
Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients. Transplantation. 2016 Jan; 100(1):141-6.
Score: 0.029